Phencyclidine Causing Opsoclonus and Myoclonus in a Four-month-old
David Oleson1, Michael Dowling1
1Pediatric Neurology, UT Southwestern Medical Center
Objective:
To report a case of phencyclidine intoxication causing opsoclonus and myoclonus in an infant. 
Background:
Saccadic intrusions, when seen in pediatric patients, raise a concern for a possible paraneoplastic syndrome. Specifically, opsoclonus, with and without myoclonus, raises a concern for neuroblastoma. We report a case of opsoclonus and myoclonus in an infant, whose evaluation for neuroblastoma was negative, but who was found to have a positive urine comprehensive drug profile for phencyclidine. Opsoclonus can be rarely seen with PCP intoxication, and this was the presumed diagnosis in this patient, whose opsoclonus and myoclonus resolved over the course of hospitalization. 
Design/Methods:
NA
Results:

A healthy 4-month-old girl presented to the emergency department with symptoms of vomiting and diarrhea. During physical evaluation, patient’s mother shared that she recently started having chaotic eye movements. She also had been having jerking movements of her arms and legs periodically. A video was uploaded and reviewed by the neurology team, who was concerned that the movements appeared to be consistent with opsoclonus. She was admitted for further evaluation. 

Upon evaluation by both neurology and ophthalmology, there was agreement that movements were consistent with opsoclonus and myoclonus. Patient also was thought to have a distended abdomen. An ultrasound of the abdomen found no abdominal mass. MRI of brain, spine, chest and abdomen were also unrevealing.  

Meanwhile, the initial urine drug screen was positive for phencyclidine (PCP). Toxicology was consulted and initially suggested that this could be a false positive result. Ultimately, the comprehensive urine drug profile confirmed PCP in two separate samples of urine. As these results returned, patient’s opsoclonus and myoclonus gradually improved until they resolved by day 4 of hospitalization. Family later admitted to presence of PCP in the home. 

Our patient followed up with neurology six months after discharge, with normal development and no noticeable sequelae.  

Conclusions:
NA
10.1212/WNL.0000000000217687
Disclaimer: Abstracts were not reviewed by Neurology® and do not reflect the views of Neurology® editors or staff.